Evaluation of the Donepezil and Rivastigmine co – administration on the cognitive deficits induced by EcT: A Randomized Double Blind Clinical Trial
Phase 3
- Conditions
- EcT in patients with Mood Disorders.Bipolar affective disorder
- Registration Number
- IRCT20171229038124N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Schizophrenia Disorder
Schizoaffective Disorder
Bipolar Mood Disorder
Major Depressive Disorder
ECT 6-12 Sessions
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of cognitive function by MMSE. Timepoint: In the first, middle and end of the period of ECT Therapy. Method of measurement: MMSE.
- Secondary Outcome Measures
Name Time Method